Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001534969-24-000085
Filing Date
2024-05-08
Accepted
2024-05-08 16:13:07
Documents
79
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sera-20240331.htm   iXBRL 10-Q 1255606
2 EX-31.1 sera-20240331x10qxex311.htm EX-31.1 8570
3 EX-31.2 sera-20240331x10qxex312.htm EX-31.2 8577
4 EX-32.1 sera-20240331x10qxex321.htm EX-32.1 6108
  Complete submission text file 0001534969-24-000085.txt   6736860

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sera-20240331.xsd EX-101.SCH 46879
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sera-20240331_cal.xml EX-101.CAL 79629
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sera-20240331_def.xml EX-101.DEF 188318
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sera-20240331_lab.xml EX-101.LAB 610593
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sera-20240331_pre.xml EX-101.PRE 425765
82 EXTRACTED XBRL INSTANCE DOCUMENT sera-20240331_htm.xml XML 963528
Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Filer) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40606 | Film No.: 24926225
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)